|
2025
|
G/S
|
Scientific research in the field of prevention and treatment of metabolic and cardiovascular dise... |
|
|
G/S
|
Scientific research in the field of prevention and treatment of cardiovascular diseases; providin... |
|
|
G/S
|
Organization and conducting of workshops, seminars and training courses for medical care, prevent... |
|
|
G/S
|
Organization and conducting of workshops, seminars and
training courses for medical care, preven... |
|
|
G/S
|
Scientific research in the field of prevention and treatment
of cardiovascular diseases; providi... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the ali... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Downloadable computer software and downloadable mobile
applications for assisting patients with ... |
|
|
G/S
|
Provision of medical research information and scientific information in the field of oncology |
|
|
G/S
|
Downloadable computer software and downloadable mobile applications for assisting patients with s... |
|
2024
|
G/S
|
Provision of medical research information and scientific information in the field of oncology. |
|
|
G/S
|
Provision of medical research information and scientific
information in the field of oncology. |
|
|
Invention
|
System and method to determine critical process parameters for a continuous viral inactivation re... |
|
|
Invention
|
Process for preparing glucopyranosyl-substituted benzyl-benzene derivatives.
The present inventi... |
|
|
Invention
|
Linked perfusion to continuous-flow stirred-tank reactor cell culture system.
Methods of protein... |
|
|
Invention
|
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an ora... |
|
|
Invention
|
Pharmaceutical composition, methods for treating and uses thereof.
The present invention relates... |
|
|
Invention
|
Uses of dpp iv inhibitors.
The specification describes the use of selected DPP IV inhibitors for... |
|
|
G/S
|
Scientific research in the field of prevention and treatment of metabolic disease; providing medi... |
|
|
Invention
|
Dpp iv inhibitor formulations.
The present invention relates to pharmaceutical compositions of D... |
|
|
G/S
|
Medical and scientific research in the fields of metabolic diseases, providing medical and scient... |
|
|
G/S
|
Medical and scientific research in the fields of metabolic diseases; providing medical and scient... |
|
|
Invention
|
Cell-controlled perfusion in continuous culture.
Methods of protein production in continuous per... |
|
|
Invention
|
Recombinant rhabdovirus encoding for a cd80 extracellular domain fc-fusion protein.
The present ... |
|
|
Invention
|
Aldosterone synthase inhibitors for treating chronic kidney disease.
The present invention relat... |
|
|
Invention
|
Cell retention device and method.
The subject technology relates to a cell retention device and ... |
|
|
Invention
|
Synthesis of morpholine derivatives and compounds therefore. 177 are as herein defined. |
|
|
Invention
|
Nebulizer and cartridge.
A cartridge and a nebulizer for nebulizing a fluid as well as a method ... |
|
|
Invention
|
Cardio- and renoprotective antidiabetic therapy.
The present invention relates to a certain DPP-... |
|
|
Invention
|
Use of anti-sirp-alpha antibodies to treat cancer. The present disclosure relates to the treatmen... |
|
|
Invention
|
Use of anti-sirp-alpha antibodies to treat a liver disease or disorder. The present disclosure re... |
|
|
Invention
|
Heteroaryl carboxamide compounds as inhibitors of ripk2.
The present invention relates to compou... |
|
|
Invention
|
Cancer treatment with a her2 inhibitor and a cyp3a and/or p-gp modulator. The present invention r... |
|
|
Invention
|
Myeloid-derived growth factor for use in treating or preventing a liver disorder. The present inv... |
|
|
G/S
|
Scientific research in the field of prevention and treatment of metabolic diseases; providing med... |
|
|
G/S
|
Scientific research in the field of prevention and treatment
of metabolic diseases; providing me... |
|
|
G/S
|
Medical and scientific research in the fields of metabolic
diseases, providing medical and scien... |
|
|
G/S
|
Medical and scientific research in the field of mental health; providing medical and scientific r... |
|
|
Invention
|
Bispecific anti-vegf and anti-trkb binding molecules for the treatment of eye diseases.
This inv... |
|
|
Invention
|
Inhibitors of trpc6 for treating focal segmental glomerulosclerosis. Disclosed are methods for tr... |
|
|
Invention
|
Inhibitors of trpc6 for treating focal segmental glomerulosclerosis.
Disclosed are methods for t... |
|
|
Invention
|
Novel substituted pyrazine-carboxamide derivatives.
The present invention relates to compounds o... |
|
|
Invention
|
Soluble guanylate cyclase activators for treating clinically significant portal hypertension and ... |
|
|
Invention
|
Cis-substituted 5-(hydroxymethyl)morpholine-2-carboxamides as agonists of sstr4.
The present dis... |
|
|
Invention
|
Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase... |
|
|
Invention
|
R)-5-(hydroxymethyl)morpholine-2-carboxamides as agonists of sstr4. ciscis-5-(hydroxymethyl)morph... |
|
|
Invention
|
Process for the manufacture of a her2 inhibitor.
The present invention relates to a process for ... |
|
|
Invention
|
Process for the manufacture of a her2 inhibitor. The present invention relates to a process for t... |
|
|
Invention
|
[1,3]diazino[5,4-d]pyrimidines as her2 inhibitors.
The present invention relates to new [1,3]dia... |
|
|
Invention
|
Holding device for dispensing devices for substance dispensing of at least one therapeutically an... |
|
|
Invention
|
Methods for the treatment and prevention of gpp.
The present invention relates to the treatment ... |
|
|
Invention
|
Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer.
Th... |
|
|
Invention
|
Anti-il-23 antibodies.
The present invention relates to anti-IL-23p19 binding compounds, in part... |
|
|
Invention
|
New therapeutic combinations for the treatment of progressive fibrosing interstitial lung disease... |
|
|
Invention
|
New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing int... |
|
2023
|
Invention
|
Tetrazole derivatives as trpa1 inhibitors.
The present disclosure provides certain tetrazole der... |
|
|
Invention
|
Recombinant expression of myeloid-derived growth factor. The present invention generally relates ... |
|
2022
|
Invention
|
Methods and molecules for rna interference (rnai).
The invention provides a method of suppressin... |
|
|
Invention
|
Trpc6 inhibitory compounds for treating sepsis.
The present invention relates to compounds of fo... |
|
|
Invention
|
Novel tetrahydroquinolines and proteolysis targeting chimera (protacs) comprising them as degrade... |
|
|
Invention
|
Treatment and prevention of alcoholic liver disease.
Methods of treating or preventing alcoholic... |
|
|
Invention
|
Identification of common tumor-specific t cell receptors and antigens.
The present invention rel... |
|
|
Invention
|
Chiral synthons for the synthesis of chiral phosphorothioates.
This invention relates to compoun... |
|
|
Invention
|
Process for purifying and enriching proteins, nucleic acids or viruses using an aqueous two-phase... |
